Skip navigation

Examine Disruptions in Specialty Drug Distribution and the Impact on Access, Quality and Cost

January 24-25, 2019
  • Las Vegas, NV

CBI’s Specialty Therapies is back for the 16th year! Join the healthcare community in Las Vegas to tackle the challenges of paying for innovative therapies that are conquering or controlling diseases that were once considered untreatable. Payers, specialty pharmacies and pharmaceutical executives will gather for an open exchange of ideas on the latest challenges and trends. Discussions will focus on how to control costs while increasing patient satisfaction and adherence.

With a range of topics that include adapting value-based design strategies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, the biosimilars pipeline and anticipated access barriers, comparing drug channels for therapies, and paying for high-tech therapies, you won’t want to miss it!

WHAT THE INDUSTRY IS SAYING:

I found the program to be well-designed
and stimulating, well worth my time.

Executive Director, MidAtlantic Business Group on Health

Class act!

Director, Specialty Pharmacy Programs, BlueCross BlueShield South Carolina

The specialty pharmacy arena is constantly evolving.
Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOLs and prepare for the challenges that they are currently
dealing with or will be facing in the near future.

Director, Clinical Pharmacy, BlueCross BlueShield Tennessee

Specialty Therapies 2019

Examine Disruptions in Specialty Drug Distribution and the Impact on Access, Quality and Cost

CBI’s Specialty Therapies is back for the 16th year! Join the healthcare community in Las Vegas to tackle the challenges of paying for innovative therapies that are conquering or controlling diseases that were once considered untreatable. Payers, specialty pharmacies and pharmaceutical executives will gather for an open exchange of ideas on the latest challenges and trends. Discussions will focus on how to control costs while increasing patient satisfaction and adherence.

With a range of topics that include adapting value-based design strategies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, the biosimilars pipeline and anticipated access barriers, comparing drug channels for therapies, and paying for high-tech therapies, you won’t want to miss it!

WHAT THE INDUSTRY IS SAYING:

I found the program to be well-designed
and stimulating, well worth my time.

Executive Director, MidAtlantic Business Group on Health

Class act!

Director, Specialty Pharmacy Programs, BlueCross BlueShield South Carolina

The specialty pharmacy arena is constantly evolving.
Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOLs and prepare for the challenges that they are currently
dealing with or will be facing in the near future.

Director, Clinical Pharmacy, BlueCross BlueShield Tennessee